Literature DB >> 1083868

Reaginic antibody formation in the mouse. VII. Induction of suppressor T cells for IgE and IgG antibody responses.

K Takatsu, K Ishizaka.   

Abstract

Intravenous injections of urea-denatured ovalbumin (UD-OA) into OA-primed high responder mice suppressed the antibody response not only to the priming antigen but also to subsequent immunization with dinitrophenyl derivatives of OA (DNP-OA). The transfer of normal spleen cells or OA-primed spleen cells into UD-OA-treated animals did not restore the capacity of responding to DNP-OA to form anti-DNP IgE and IgG antibodies. The transfer of splenic T cell fraction from the UD-OA-treated animals into normal syngeneic mice diminished both IgE and IgG antibody responses of the recipients to DNP-OA. The B cell-rich fraction from the same donors failed to affect the anti-hapten antibody response and enhanced anti-cancer (OA) IgG antibody response of the recipients. It was also found that the transfer of T cell-rich fraction of OA-primed spleen cells failed to suppress antibody response of the recipients to DNP-OA. The results indicated that spleen cells of UD-OA-treated mice contained suppressor T cells which are distinct from helper cells. Suppressive activity of T cells in the UD-OA treated animals was specific for OA. The transfer of the T cell-rich fraction failed to suppress anti-DNP antibody response of the recipients to DNP-KLH.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1083868

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  Can persistent IgE responses be suppressed?

Authors:  D M Kemeny; D Diaz-Sanchez
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  Regulation of anti-hapten antibody response by chemically modified carrier antigen preferentially provoking delayed-type hypersensitivity. I. Possible T-T cell interaction in the suppression of antibody response.

Authors:  A Machida; Y Kumazawa; K Mizunoe
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

3.  Suppression of immunoglobulin synthesis and secretion by peripheral blood lymphocytes from normal donors.

Authors:  S A Schwartz; L Shou; R A Good; Y S Choi
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

4.  In vitro synthesis of IgE by human peripheral blood leucocytes. II modulation of IgE B cell activity by isotype-specific regulatory T cells.

Authors:  G H Holt; K J Turner; B J Holt
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

5.  Regulation of the IgE antibody response in mice. II. Radioresistance of established IgE antibody production.

Authors:  S H Peeters; B G Carter
Journal:  Immunology       Date:  1981-05       Impact factor: 7.397

6.  Transfer factor therapy in hyperimmunoglobulinaemia E syndrome.

Authors:  H H Kesarwala; R V Prasad; R Szep; E Oldman; S Lane; P S Papageorgiou
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

7.  Increase in numbers of CD8 positive lymphocytes and eosinophils in peripheral blood of subjects with late asthmatic reactions induced by toluene diisocyanate.

Authors:  S Finotto; L M Fabbri; V Rado; C E Mapp; P Maestrelli
Journal:  Br J Ind Med       Date:  1991-02

Review 8.  Mechanisms of reaginic hypersensitivity and immunotherapy.

Authors:  K Ishizaka; T Ishizaka
Journal:  Lung       Date:  1978       Impact factor: 2.584

9.  Connection of atopic disease in Japanese patients with juvenile dermatomyositis based on serum IgE levels.

Authors:  T Ishida; M Ohashi; Y Matsumoto; J Morikawa; R Sasaki
Journal:  Clin Rheumatol       Date:  1993-03       Impact factor: 2.980

10.  Adjuvant and suppressive effects of Grass Conjuvac and other alginate conjugates on IgG and IgE antibody responses in mice.

Authors:  W A Taylor; D Sheldon; J W Spicer
Journal:  Immunology       Date:  1981-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.